| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 |
| D824725 | MACKLIN | 双嘧达莫 | 98% | 75元/5g; 245元/25g; 776元/100g; 3277元/500g; | 展开 |
储存:室温 状态:黄色到黄色绿色粉末 折射率:1.666 |
| D795361 | MACKLIN | 双嘧达莫 | 10mM in DMSO | 376元/1ml; | 展开 |
|
| D2274 | TCI | Dipyridamole | >98.0%(T)(HPLC) | 405元/5G; 1265元/25G; | 展开 |
基本信息 | 纯度/分析方法 | >98.0%(T)(HPLC) | | 分子式/分子量 | C24H40N8O4 = 504.64 | | 外观与形状(20℃) | 固体 | | 应避免的情况 | 光 | | Reaxys-RN | 68373 | | PubChem物质ID | 87568711 | | SDBS (AIST Spectral DB) | 19363 | | Merck Index (14) | 3346 | | MDL编号 | MFCD00010555 |
技术规格 | Appearance | Light yellow to Yellow to Orange powder to crystal | | Purity(HPLC) | min. 98.0 area% | | Purity(Nonaqueous Titration) | min. 98.0 % | | Solubility in THF | almost transparency |
物性(参考值) 安全信息 | 图形或危害标志 |   | | 信号词 | 危险 | | 危险性说明 | H315 : 造成皮肤刺激。 H319 : 造成严重眼刺激。 H370 : 会损害器官。
| | 防范说明 | P501 : 将内装物/容器送到批准的废物处理厂处理。 P260 : 不要吸入粉尘/ 烟/ 气体/ 烟雾/ 蒸气/ 喷雾。 P270 : 使用本产品时不要进食、饮水或吸烟。 P264 : 作业后彻底清洗皮肤。 P280 : 戴防护手套/戴防护眼罩/戴防护面具。 P302 + P352 : 如皮肤沾染:用水充分清洗。 P337 + P313 : 如仍觉眼刺激:求医/就诊。 P305 + P351 + P338 : 如进入眼睛:用水小心冲洗几分钟。如戴隐形眼镜并可方便地取出,取出隐形眼镜。继续冲洗。 P308+P311 : 如接触到或有疑虑:呼叫急救中心/医生。 P362+P364 : 脱掉沾污的衣服,清洗后方可重新使用。 P332 + P313 : 如发生皮肤刺激:求医/就诊。 P405 : 存放处须加锁。
|
相关法规 |
| 125517 | J&K | Dipyridamole | 98%, 一种磷酸二酯酶抑制剂 | 371元/5G; 1131元/25G; 3724元/100G; | 展开 |
基本信息 | 分子式 | C24H40N8O4 | | 分子量 | 504.63 | | 熔点 | 165-166 | | MDL编码 | MFCD00010555 | | Merck | 13,3381 | | EINECS 编号 | 200-374-7 | 产品描述 Dipyridamole是一种磷酸二酯酶抑制剂,通过红细胞和血管内皮细胞,抑制腺苷的摄取和代谢。 靶点(IC50 & Targe) PDE 参考文献 [1] Klabunde RE. Eur J Pharmacol, 1983, 93(1-2):21-6. 安全信息 | 图形或危害标志 |  | | 提示语 | Warning | | 危险说明 | H315 H319 H335 | | 防范说明 | P261 P305+P351+P338 | | WGK | 2 | | RTECS | KK7450000 | | TSCA | 否 |
|
| Y0000802 | | Dipyridamole for peak identification | European Pharmacopoeia (EP) Reference Standard | 1572.27元/ ; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 磷酸二酯酶 V 选择性抑制剂 (PDE 5);强效冠脉扩张药物;腺苷转运抑制剂;血小板聚集抑制剂。 包装 Unit quantity: 2 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C24H40N8O4 | | 分子量 | 504.63 | | MDL编号 | MFCD00010555 | | PubChem化学物质编号 | 329831157 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | mp | 165-166 ℃ (lit.) | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | OCCN(CCO)c1nc(N2CCCCC2)c3nc(nc(N4CCCCC4)c3n1)N(CCO)CCO | | InChI | 1S/C24H40N8O4/c33-15-11-31(12-16-34)23-26-20-19(21(27-23)29-7-3-1-4-8-29)25-24(32(13-17-35)14-18-36)28-22(20)30-9-5-2-6-10-30/h33-36H,1-18H2 | | InChI key | IZEKFCXSFNUWAM-UHFFFAOYSA-N | | Gene Information | human ... PDE10A(10846), PDE1A(5136), PDE1B(5153), PDE1C(5137), PDE2A(5138), PDE3A(5139), PDE3B(5140), PDE4A(5141), PDE4B(5142), PDE4C(5143), PDE4D(5144), PDE5A(8654), PDE6A(5145), PDE6B(5158), PDE6C(5146), PDE6D(5147), PDE6G(5148), PDE6H(5149), PDE7A(5150), PDE7B(27115), PDE8A(5151), PDE8B(8622), PDE9A(5152), SLC29A1(2030) |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H315 - H319 - H335 | | 预防措施声明 | P302 + P352 - P305 + P351 + P338 | | 危险分类 | Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 | | 靶器官 | Respiratory system | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 2 |
|
| D9766 | Sigma-Aldrich | Dipyridamole | ≥98% (HPLC) | 422.15元/1 G; 1430.65元/5 G; 2351.26元/10 G; 4054.86元/25 G; | 展开 |
产品说明 一般描述 双嘧达莫阻止细胞摄取腺苷。作为一种平衡核苷转运蛋白 1 (ENT1) 抑制剂发挥作用。 应用 双嘧达莫已用于: - 进行体外生长抑制试验 (40)
- 测定其预防子宫肌层收缩的能力 (41)
- 确定其对烟酰胺腺嘌呤二核苷酸 (NAD +) 诱导的细胞内三磷酸腺苷 (ATP) 水平增加的作用 (42)
- ,防止烟酰胺核苷 (NR) 诱导的轴突保护作用 (43)
包装 1, 5, 10, 25 g in glass bottle 生化/生理作用 磷酸二酯酶 V 选择性抑制剂 (PDE 5);强效冠脉扩张药物;腺苷转运抑制剂;血小板聚集抑制剂。 特点和优势 这种化合物是环核苷酸研究的特色产品。点击此处发现更多特色环核苷酸产品。在sigma.com/discover-bsm可了解更多关于生物活性小分子的其他研究领域。 该化合物出现在受体分类和信号转导手册的磷酸二酯酶页,点击此处。 该化合物由 Boehringer Ingelheim 开发。想要浏览其他由制药公司开发的化合物以及已批准药物/候选药物清单,请单击此处。 基本信息 | 经验(实验)分子式 | C24H40N8O4 | | 分子量 | 504.63 | | EC 号 | 200-374-7 | | MDL编号 | MFCD00010555 | | PubChem化学物质编号 | 24277705 |
产品性质 | 质量水平 | 200 | | 测定 | ≥98% (HPLC) | | 形式 | powder | | 颜色 | yellow | | mp | 165-166 ℃ (lit.) | | 溶解性 | DMSO: soluble ethanol: soluble | | 创始人 | Boehringer Ingelheim | | 储存温度 | room temp | | SMILES string | OCCN(CCO)c1nc(N2CCCCC2)c3nc(nc(N4CCCCC4)c3n1)N(CCO)CCO | | InChI | 1S/C24H40N8O4/c33-15-11-31(12-16-34)23-26-20-19(21(27-23)29-7-3-1-4-8-29)25-24(32(13-17-35)14-18-36)28-22(20)30-9-5-2-6-10-30/h33-36H,1-18H2 | | InChI key | IZEKFCXSFNUWAM-UHFFFAOYSA-N | | Gene Information | human ... CYP1A2(1544), PDE10A(10846), PDE1A(5136), PDE1B(5153), PDE1C(5137), PDE2A(5138), PDE3A(5139), PDE3B(5140), PDE4A(5141), PDE4B(5142), PDE4C(5143), PDE4D(5144), PDE5A(8654), PDE6A(5145), PDE6B(5158), PDE6C(5146), PDE6D(5147), PDE6G(5148), PDE6H(5149), PDE7A(5150), PDE7B(27115), PDE8A(5151), PDE8B(8622), PDE9A(5152), SLC29A1(2030) mouse ... Slc29a1(63959) |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H315 - H319 - H335 | | 预防措施声明 | P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338 | | 危险分类 | Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 | | 靶器官 | Respiratory system | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 2 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable | | 个人防护装备 | dust mask type N95 (US), Eyeshields, Gloves |
|
| D2850000 | | Dipyridamole | European Pharmacopoeia (EP) Reference Standard | 1277.32元/ ; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 磷酸二酯酶 V 选择性抑制剂 (PDE 5);强效冠脉扩张药物;腺苷转运抑制剂;血小板聚集抑制剂。 包装 Unit quantity: 50 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C24H40N8O4 | | 分子量 | 504.63 | | MDL编号 | MFCD00010555 | | PubChem化学物质编号 | 329798756 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | mp | 165-166 ℃ (lit.) | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | OCCN(CCO)c1nc(N2CCCCC2)c3nc(nc(N4CCCCC4)c3n1)N(CCO)CCO | | InChI | 1S/C24H40N8O4/c33-15-11-31(12-16-34)23-26-20-19(21(27-23)29-7-3-1-4-8-29)25-24(32(13-17-35)14-18-36)28-22(20)30-9-5-2-6-10-30/h33-36H,1-18H2 | | InChI key | IZEKFCXSFNUWAM-UHFFFAOYSA-N | | Gene Information | human ... PDE10A(10846), PDE1A(5136), PDE1B(5153), PDE1C(5137), PDE2A(5138), PDE3A(5139), PDE3B(5140), PDE4A(5141), PDE4B(5142), PDE4C(5143), PDE4D(5144), PDE5A(8654), PDE6A(5145), PDE6B(5158), PDE6C(5146), PDE6D(5147), PDE6G(5148), PDE6H(5149), PDE7A(5150), PDE7B(27115), PDE8A(5151), PDE8B(8622), PDE9A(5152), SLC29A1(2030) |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H315 - H319 - H335 | | 预防措施声明 | P302 + P352 - P305 + P351 + P338 | | 危险分类 | Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 | | 靶器官 | Respiratory system | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 2 |
|
| BP131 | | Dipyridamole | British Pharmacopoeia (BP) Reference Standard | 2189.77元/100 MG; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 磷酸二酯酶 V 选择性抑制剂 (PDE 5);强效冠脉扩张药物;腺苷转运抑制剂;血小板聚集抑制剂。 包装 Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C24H40N8O4 | | 分子量 | 504.63 | | EC 号 | 200-374-7 | | MDL编号 | MFCD00010555 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | BP | | mp | 165-166 ℃ (lit.) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | OCCN(CCO)c1nc(N2CCCCC2)c3nc(nc(N4CCCCC4)c3n1)N(CCO)CCO | | InChI | 1S/C24H40N8O4/c33-15-11-31(12-16-34)23-26-20-19(21(27-23)29-7-3-1-4-8-29)25-24(32(13-17-35)14-18-36)28-22(20)30-9-5-2-6-10-30/h33-36H,1-18H2 | | InChI key | IZEKFCXSFNUWAM-UHFFFAOYSA-N | | Gene Information | human ... PDE10A(10846), PDE1A(5136), PDE1B(5153), PDE1C(5137), PDE2A(5138), PDE3A(5139), PDE3B(5140), PDE4A(5141), PDE4B(5142), PDE4C(5143), PDE4D(5144), PDE5A(8654), PDE6A(5145), PDE6B(5158), PDE6C(5146), PDE6D(5147), PDE6G(5148), PDE6H(5149), PDE7A(5150), PDE7B(27115), PDE8A(5151), PDE8B(8622), PDE9A(5152), SLC29A1(2030) |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H315 - H319 - H335 | | 预防措施声明 | P305 + P351 + P338 | | 危险分类 | Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 | | 靶器官 | Respiratory system | | 储存分类代码 | 13 - Non Combustible Solids | | WGK | WGK 2 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 1220506 | USP | Dipyridamole | United States Pharmacopeia (USP) Reference Standard | 3426.58元/200 MG; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 磷酸二酯酶 V 选择性抑制剂 (PDE 5);强效冠脉扩张药物;腺苷转运抑制剂;血小板聚集抑制剂。 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C24H40N8O4 | | 分子量 | 504.63 | | MDL编号 | MFCD00010555 | | PubChem化学物质编号 | 329749652 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | USP | | mp | 165-166 ℃ (lit.) | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | SMILES string | OCCN(CCO)c1nc(N2CCCCC2)c3nc(nc(N4CCCCC4)c3n1)N(CCO)CCO | | InChI | 1S/C24H40N8O4/c33-15-11-31(12-16-34)23-26-20-19(21(27-23)29-7-3-1-4-8-29)25-24(32(13-17-35)14-18-36)28-22(20)30-9-5-2-6-10-30/h33-36H,1-18H2 | | InChI key | IZEKFCXSFNUWAM-UHFFFAOYSA-N | | Gene Information | human ... PDE10A(10846), PDE1A(5136), PDE1B(5153), PDE1C(5137), PDE2A(5138), PDE3A(5139), PDE3B(5140), PDE4A(5141), PDE4B(5142), PDE4C(5143), PDE4D(5144), PDE5A(8654), PDE6A(5145), PDE6B(5158), PDE6C(5146), PDE6D(5147), PDE6G(5148), PDE6H(5149), PDE7A(5150), PDE7B(27115), PDE8A(5151), PDE8B(8622), PDE9A(5152), SLC29A1(2030) |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H315 - H319 - H335 | | 预防措施声明 | P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338 | | 危险分类 | Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 | | 靶器官 | Respiratory system | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 2 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| BP1102 | | Dipyridamole impurity standard | British Pharmacopoeia (BP) Reference Standard | 1989元/25 MG; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 磷酸二酯酶 V 选择性抑制剂 (PDE 5);强效冠脉扩张药物;腺苷转运抑制剂;血小板聚集抑制剂。 包装 Unit quantity: 25 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C24H40N8O4 | | 分子量 | 504.63 | | MDL编号 | MFCD00010555 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | BP | | mp | 165-166 ℃ (lit.) | | 格式 | mixture | | 储存温度 | 2-8℃ | | SMILES string | OCCN(CCO)c1nc(N2CCCCC2)c3nc(nc(N4CCCCC4)c3n1)N(CCO)CCO | | InChI | 1S/C24H40N8O4/c33-15-11-31(12-16-34)23-26-20-19(21(27-23)29-7-3-1-4-8-29)25-24(32(13-17-35)14-18-36)28-22(20)30-9-5-2-6-10-30/h33-36H,1-18H2 | | InChI key | IZEKFCXSFNUWAM-UHFFFAOYSA-N | | Gene Information | human ... PDE10A(10846), PDE1A(5136), PDE1B(5153), PDE1C(5137), PDE2A(5138), PDE3A(5139), PDE3B(5140), PDE4A(5141), PDE4B(5142), PDE4C(5143), PDE4D(5144), PDE5A(8654), PDE6A(5145), PDE6B(5158), PDE6C(5146), PDE6D(5147), PDE6G(5148), PDE6H(5149), PDE7A(5150), PDE7B(27115), PDE8A(5151), PDE8B(8622), PDE9A(5152), SLC29A1(2030) |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H315 - H319 - H335 | | 预防措施声明 | P261 - P280 - P280 - P302 + P352 - P304 + P340 + P312 - P305 + P351 + P338 | | 危险分类 | Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 | | 靶器官 | Respiratory system | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 2 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 079856 | Fluorochem | 2,2',2'',2'''-((4,8-Di(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,6-diyl)bis(azanetriyl))tetraethanol | 95% | 264元/10g; 638元/25g; 2420元/100g; | 展开 |
基本信息 | CAS Number | 58-32-2 | | MDL Number | MFCD00010555 | | Melting Point | 165-166℃ |
安全信息 | 图形或危害标志 |  | | 危险性说明 | H302: Harmful if swallowed. H315: Causes skin irritation. H319: Causes serious eye irritation. H335: May cause respiratory irritation.
| | 防范说明 | P233: Keep container tightly closed. P260: Do not breathe . P261: Avoid breathing . P264: Wash hands thoroughly after handling. P270: Do not eat, drink or smoke when using this product. P271: Use only outdoors or in a well-ventilated area. P280: Wear . P301 + P312: IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell. P302 + P352: IF ON SKIN: Wash with plenty of soap and water. P304: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing.. P304 + P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P305 + P351 + P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P312: Call a POISON CENTER or doctor/physician if you feel unwell. P321: Specific treatment (see relevant procedures. on this label). P330: Rinse mouth. P332 + P313: If skin irritation occurs: Get medical advice/ attention. P337 + P313: If eye irritation persists: Get medical advice/attention. P340: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P362: Take off contaminated clothing and wash before reuse. P403: Store in a well-ventilated place. P403 + P233: Store in a well-ventilated place. Keep container tightly closed. P405: Store locked up. P501: Dispose of contents/container to in accordance with local regulation .
|
|